Abstract

Watch the video or read the poster to learn more about:Current challenges in manufacturing CAR-T cells and approaches to overcoming these An overview of Miltenyi Biotec´s cell manufacturing platform and a deep dive into CliniMACS Prodigy® Instrument componentsInsights into the fully automated CAR -T cell manufacturing processOptions for non-viral engineeringSophia Lollies is as Global Product Manager for the clinical engineered ceels portfolio, including CAR T cell immunotherapy, at Miltenyi Biotec. Since 2021 she has been working with R&D and the Clinical Development team to advance the development of enabling tools for CAR and TCR T cell therapy. Before that, as part of the Industry Process Developemnt team, Sophia supported the development of clinical applications on the CliniMACS®  Prodigy for industrial customers. 

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.